WHO ICTRP trial
ECMT-154™ for the Topical Treatment of Eczema
ACTRN12621001096842 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12621001096842 |
|---|---|
| Public title | ECMT-154™ for the Topical Treatment of Eczema |
| Scientific title | Randomised Controlled Trial of ECMT-154™ vs Vehicle Control for the Topical Treatment of Eczema in Adults |
| Primary sponsor | Manuka Biosciences |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | New Zealand |
| Conditions | Eczema; Eczema;Skin - Dermatological conditions |
| Interventions | Manuka-oil based 1% ECMT-154 cream Applied topically, twice daily, for six weeks The amount applied will vary by eczema spread. Participants are recommended to apply the treatment liberally to the affected areas. A weekly participant diary… |
| Registration date | Aug 18, 2021 |
| Target size | 118 |
| Secondary IDs | MBS02 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: